Fred Alger Management, LLC Neogenomics Inc Transaction History

Fred Alger Management, LLC

  • $20.2 Billion
  • Q2 2025

A detailed history of Fred Alger Management, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 806,649 shares of NEO stock, worth $4.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
806,649
Previous 1,574,777 48.78%
Holding current value
$4.9 Million
Previous $14.9 Million 60.55%
% of portfolio
0.03%
Previous 0.09%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$6.4 - $10.27 $4.92 Million - $7.89 Million
-768,128 Reduced 48.78%
806,649 $5.9 Million
Q1 2025

May 15, 2025
SELL
$9.09 - $18.61 $1.26 Million - $2.57 Million
-138,182 Reduced 8.07%
1,574,777 $14.9 Million
Q4 2024

Feb 14, 2025
SELL
$13.0 - $18.43 $909,194 - $1.29 Million
-69,938 Reduced 3.92%
1,712,959 $28.2 Million
Q3 2024

Nov 14, 2024
SELL
$13.4 - $17.73 $697,001 - $922,225
-52,015 Reduced 2.83%
1,782,897 $26.3 Million
Q2 2024

Aug 14, 2024
SELL
$13.01 - $15.77 $6.57 Million - $7.96 Million
-504,854 Reduced 21.58%
1,834,912 $25.5 Million
Q1 2024

May 15, 2024
BUY
$14.06 - $16.79 $6.52 Million - $7.79 Million
463,936 Added 24.73%
2,339,766 $36.8 Million
Q4 2023

Feb 14, 2024
BUY
$11.67 - $20.73 $6.35 Million - $11.3 Million
544,130 Added 40.86%
1,875,830 $30.4 Million
Q3 2023

Nov 14, 2023
BUY
$12.15 - $17.85 $4.36 Million - $6.41 Million
359,120 Added 36.92%
1,331,700 $16.4 Million
Q2 2023

Aug 14, 2023
BUY
$14.1 - $19.83 $13.7 Million - $19.3 Million
972,525 Added 1768227.25%
972,580 $15.6 Million
Q1 2023

May 15, 2023
SELL
$9.09 - $19.45 $6.84 Million - $14.6 Million
-752,150 Reduced 99.99%
55 $0
Q4 2022

Feb 14, 2023
SELL
$6.45 - $12.07 $5.69 Million - $10.6 Million
-881,699 Reduced 53.96%
752,205 $6.95 Million
Q3 2022

Nov 14, 2022
BUY
$7.86 - $12.91 $8.33 Million - $13.7 Million
1,060,294 Added 184.85%
1,633,904 $14.1 Million
Q2 2022

Aug 15, 2022
SELL
$7.06 - $13.97 $1.86 Million - $3.68 Million
-263,361 Reduced 31.47%
573,610 $4.68 Million
Q1 2022

May 16, 2022
SELL
$12.15 - $35.28 $151,170 - $438,953
-12,442 Reduced 1.46%
836,971 $10.2 Million
Q4 2021

Feb 14, 2022
SELL
$30.49 - $48.49 $425,609 - $676,871
-13,959 Reduced 1.62%
849,413 $29 Million
Q3 2021

Nov 15, 2021
SELL
$41.66 - $52.52 $48.4 Million - $61.1 Million
-1,162,746 Reduced 57.39%
863,372 $41.6 Million
Q2 2021

Aug 16, 2021
SELL
$36.62 - $51.69 $8.01 Million - $11.3 Million
-218,847 Reduced 9.75%
2,026,118 $91.5 Million
Q1 2021

May 17, 2021
BUY
$41.56 - $59.88 $9.76 Million - $14.1 Million
234,760 Added 11.68%
2,244,965 $108 Million
Q4 2020

Feb 16, 2021
BUY
$36.08 - $56.47 $5.27 Million - $8.26 Million
146,187 Added 7.84%
2,010,205 $108 Million
Q3 2020

Nov 13, 2020
BUY
$33.26 - $40.48 $9.9 Million - $12 Million
297,563 Added 19.0%
1,864,018 $68.8 Million
Q2 2020

Aug 14, 2020
BUY
$24.21 - $31.02 $18.5 Million - $23.7 Million
765,549 Added 95.59%
1,566,455 $48.5 Million
Q1 2020

May 15, 2020
BUY
$20.5 - $34.53 $12 Million - $20.2 Million
586,202 Added 273.03%
800,906 $22.1 Million
Q4 2019

Feb 14, 2020
BUY
$18.96 - $29.84 $2.36 Million - $3.71 Million
124,259 Added 137.39%
214,704 $6.28 Million
Q3 2019

Nov 14, 2019
BUY
$19.12 - $26.24 $677,708 - $930,076
35,445 Added 64.45%
90,445 $1.73 Million
Q2 2019

Aug 14, 2019
BUY
$19.57 - $24.1 $136,990 - $168,700
7,000 Added 14.58%
55,000 $1.21 Million
Q1 2019

May 14, 2019
BUY
$12.14 - $20.46 $582,720 - $982,080
48,000 New
48,000 $982,000

Others Institutions Holding NEO

# of Institutions
307
Shares Held
129M
Call Options Held
1.1M
Put Options Held
296K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $765M
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email